About 6,340,000 results
FDA expands approval of breast cancer drug Kisqali – NBC New …
FDA approves Novartis Kisqali® to reduce risk of recurrence in …
Novartis Kisqali® shows deepening benefit in new analysis, …
FDA expands Novartis’ Kisqali label to include early breast cancer …
Novartis Wins FDA Approval of Kisqali for Early Breast Cancer
New Treatment for Early Stage Breast Cancer Gains FDA Nod
Novartis nabs broader early breast cancer nod than Eli Lilly
Latest analysis of Novartis NATALEE study shows Kisqali® …
Novartis Kisqali® Phase III NATALEE trial meets primary endpoint …
Kisqali Plus Hormone Therapy for Metastatic Breast Cancer